Anti-TNF was also reported to reduce granulocyte-macrophage colony-stimulating factor (GM-CSF) and vascular endothelial growth factor (VEGF) both in vitro and in patients with RA [26,27]. Here, CSF2 is linked to rheumatoid arthritis.